| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 1, 2024 | Jan 3, 2024 | Aclaris Therapeutics, Inc. | CEO | Sell | 47.5 | -9,125 | -17.91% | ✗ | $9.6K |
| Aug 1, 2023 | Aug 3, 2023 | Aclaris Therapeutics, Inc. | CEO | Sell | 46.3 | -4,437 | -15.64% | ✗ | $43.5K |
| Mar 17, 2023 | Mar 17, 2023 | Aclaris Therapeutics, Inc. | CEO | Buy | 91.3 | +6,300 | 96.92% | ✗ | $49.5K |
| Mar 9, 2023 | Mar 9, 2023 | Aclaris Therapeutics, Inc. | CEO | Buy | 95.0 | +6,500 | 100.00% | ✗ | $50.3K |